Related references
Note: Only part of the references are listed.Why Do So Many Drugs for Alzheimer's Disease Fail in Development? Time for New Methods and New Practices?
Robert E. Becker et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study
Wagner F. Gattaz et al.
JOURNAL OF NEURAL TRANSMISSION (2014)
Amyloid and tau: neither chicken nor egg but two partners in crime!
Johannes Attems et al.
ACTA NEUROPATHOLOGICA (2013)
Quantification of Amyloid Precursor Protein Isoforms Using Quantification Concatamer Internal Standard
Junjun Chen et al.
ANALYTICAL CHEMISTRY (2013)
Platelet-Derived Secreted Amyloid-Precursor Protein-β as a Marker for Diagnosing Alzheimer's Disease
Josef Marksteiner et al.
CURRENT NEUROVASCULAR RESEARCH (2013)
ADAM10 as a Biomarker for Alzheimer's Disease: A Study with Brazilian Elderly
Patricia Regina Manzine et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2013)
Impact of gender on platelet membrane functions of Alzheimer's disease patients
Arianna Vignini et al.
EXPERIMENTAL GERONTOLOGY (2013)
Amyloid precursor protein expression is enhanced in human platelets from subjects with Alzheimer's disease and frontotemporal lobar degeneration: A Real-time PCR study
Arianna Vignini et al.
EXPERIMENTAL GERONTOLOGY (2013)
The amyloid precursor protein: A biochemical enigma in brain development, function and disease
Natalia N. Nalivaeva et al.
FEBS LETTERS (2013)
Role of platelets in neurodegenerative diseases: a universal pathophysiology
Madhuri Behari et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2013)
Ascending monoaminergic systems alterations in Alzheimer's disease. Translating basic science into clinical care
Ludwig Trillo et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Can platelet BACE1 levels be used as a biomarker for Alzheimer's disease? Proof-of-concept study
Boris Decourt et al.
PLATELETS (2013)
An Extensive Targeted Proteomic Analysis of Disease-Related Protein Biomarkers in Urine from Healthy Donors
Brian M. Nolen et al.
PLOS ONE (2013)
Blood and plasma-based proteomic biomarker research in Alzheimer's disease
Simone Lista et al.
PROGRESS IN NEUROBIOLOGY (2013)
P-selectin paradox and dementia of the Alzheimer type: Circulating P-selectin is increased but platelet-bound P-selectin after agonist provocation is compromised
Petter Jaremo et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2013)
Glycogen synthase kinase-3β (GSK3β) expression in a mouse model of Alzheimer's disease: A light and electron microscopy study
Johanna C. Gandy et al.
SYNAPSE (2013)
Platelet immunoglobulin and amyloid precursor protein as potential peripheral biomarkers for Alzheimer's disease: findings from a pilot study
Elizabeta B. Mukaetova-Ladinska et al.
AGE AND AGEING (2012)
Increased mean platelet volume (MPV) indicating the vascular risk in Alzheimer's disease (AD)
Yusuf Yesil et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2012)
Tau alternative splicing in familial and sporadic tauopathies
Michael Niblock et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial
Celeste A. de Jager et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2012)
Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease
Isis A. Zainaghi et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Twenty years of Alzheimer's disease-causing mutations
Alison Goate et al.
JOURNAL OF NEUROCHEMISTRY (2012)
A combined proteomic and genetic analysis of the highly variable platelet proteome: From plasmatic proteins and SNPs
Michael Veitinger et al.
JOURNAL OF PROTEOMICS (2012)
Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients
Maria Zellner et al.
JOURNAL OF PROTEOMICS (2012)
Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease
Maria Bjorkqvist et al.
PLOS ONE (2012)
Alzheimer disease and platelets: how's that relevant
Silvia Catricala et al.
IMMUNITY & AGEING (2012)
Platelet biomarkers in Alzheimer's disease
Leda L. Talib et al.
WORLD JOURNAL OF PSYCHIATRY (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Amyloid Precursor Protein Processing and Alzheimer's Disease
Richard J. O'Brien et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 34 (2011)
A proteomics study reveals a predominant change in MaoB expression in platelets of healthy volunteers after high protein meat diet: relationship to the methylation cycle
Maria Zellner et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease
Orestes V. Forlenza et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2011)
Membrane cholesterol enrichment prevents Aβ-induced oxidative stress in Alzheimer's fibroblasts
Anna Pensalfini et al.
NEUROBIOLOGY OF AGING (2011)
One-carbon metabolism and Alzheimer's disease: is it all a methylation matter?
Andrea Fuso et al.
NEUROBIOLOGY OF AGING (2011)
Activated MAO-B in the brain of Alzheimer patients, demonstrated by [C-11]-L-deprenyl using whole hemisphere autoradiography
Balazs Gulyas et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease
Andrea Chincarini et al.
NEUROIMAGE (2011)
Coated-platelet levels and progression from mild cognitive impairment to Alzheimer disease
C. I. Prodan et al.
NEUROLOGY (2011)
Inhibition of phospholipase A2 in rat brain modifies different membrane fluidity parameters in opposite ways
Evelin L. Schaeffer et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Peripheral inflammatory biomarkers of Alzheimer's disease: the role of platelets
Tiziana Casoli et al.
BIOGERONTOLOGY (2010)
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease
Clifford R. Jack et al.
BRAIN (2010)
Non-Steroidal Anti-Inflammatory Drugs and Alzheimer's Disease: The Epidemiological Evidence
C. A. Szekely et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets
Barbara Borroni et al.
EXPERIMENTAL GERONTOLOGY (2010)
SCAMP5, NBEA and AMISYN: three candidate genes for autism involved in secretion of large dense-core vesicles
Dries Castermans et al.
HUMAN MOLECULAR GENETICS (2010)
Statistical Analysis of Variation in the Human Plasma Proteome
Todd H. Corzett et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Secretory phospholipase A2 type III enhances α-secretase-dependent amyloid precursor protein processing through alterations in membrane fluidity
Xiaoguang Yang et al.
JOURNAL OF LIPID RESEARCH (2010)
Quantitative Proteomics and Metabolomics Analysis of Normal Human Cerebrospinal Fluid Samples*
Marcel P. Stoop et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
β-Amyloid precursor protein and tau protein levels are differently regulated in human cerebellum compared to brain regions vulnerable to Alzheimer's type neurodegeneration
Mirsada Causevic et al.
NEUROSCIENCE LETTERS (2010)
Differences in Coated-platelet Production Between Frontotemporal Dementia and Alzheimer Disease
Calin I. Prodan et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2009)
Lithium Trial in Alzheimer's Disease: A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study
Harald Hampel et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
A novel reciprocal and biphasic relationship between membrane cholesterol and beta-secretase activity in SH-SY5Y cells and in human platelets
Wei Wei Liu et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Altered Brain Serotonin Transporter and Associated Glucose Metabolism in Alzheimer Disease
Yasuomi Ouchi et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Smoking Induces Long-Lasting Effects through a Monoamine-Oxidase Epigenetic Regulation
Jean-Marie Launay et al.
PLOS ONE (2009)
Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease
Dorotea Muck-Seler et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Monoamine oxidase inactivation: From pathophysiology to therapeutics
Marco Bortolato et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Detection of membrane fluidity in submitochondrial particles of platelets and erythrocyte membranes from Mexican patients with Alzheimer disease by intramolecular excimer formation of 1,3 dipyrenylpropane
G. G. Ortiz et al.
DISEASE MARKERS (2008)
Effects of ageing and Alzheimer's diseaseon mitochondrial function of human platelets
Chun Shi et al.
EXPERIMENTAL GERONTOLOGY (2008)
Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease
Paloma Bermejo et al.
IMMUNOLOGY LETTERS (2008)
What do we know about serotonin?
Catherine Jonnakuty et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Platelet β-secretase activity is increased in Alzheimer's disease
J. A. Johnston et al.
NEUROBIOLOGY OF AGING (2008)
Cognitive training increases platelet PLA2 activity in healthy elderly subjects
Leda L. Talib et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2008)
Rate of progression in Alzheimer's disease correlates with coated-platelet levels - a longitudinal study
Calin I. Prodan et al.
TRANSLATIONAL RESEARCH (2008)
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper et al.
JOURNAL OF NEUROCHEMISTRY (2008)
What's new in using platelet research? To unravel thrombopathies and other human disorders
Kathleen Freson et al.
EUROPEAN JOURNAL OF PEDIATRICS (2007)
Platelet phospholipase A2 activity in patients with Alzheimer's disease, vascular dementia and ischemic stroke
E. Krzystanek et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Abnormal APP processing in platelets of patients with Alzheimer's disease: correlations with membrane fluidity and cognitive decline
Isis A. Zainaghi et al.
PSYCHOPHARMACOLOGY (2007)
Coated-platelets are higher in amnestic versus nonamnestic patients with mild cognitive impairment
Calin I. Prodan et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2007)
Modifications of platelet from Alzheimer disease patients: A possible relation between membrane properties and NO metabolites
Vignini Arianna et al.
NEUROBIOLOGY OF AGING (2007)
Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases
Michael P. Mazanetz et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Coated-platelets correlate with disease progression in Alzheimer disease
Calin I. Prodan et al.
JOURNAL OF NEUROLOGY (2007)
Statin-Like Drugs for the Treatment of Brain Cholesterol Loss in Alzheimer's Disease
Biondi Elisa
CURRENT DRUG SAFETY (2007)
Elevated platelet beta-secretase activity in mild cognitive impairment
W. W. Liu et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
Carlo Ballatore et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment
Jon Valla et al.
MITOCHONDRION (2006)
The significance of the cholinergic system in the brain during aging and in Alzheimer's disease
R. Schliebs et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
The phospholipase A2 superfamily and its group numbering system
Ralph H. Schaloske et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)
Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach
R Sultana et al.
NEUROBIOLOGY OF DISEASE (2006)
Coated-platelets retain amyloid precursor protein on their surface
CI Prodan et al.
PLATELETS (2006)
Platelet amyloid precursor protein processing: A bio-marker for Alzheimer's disease
K Tang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Coated-platelets: an emerging component of the procoagulant response
GL Dale
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Reduced phospholipid breakdown in Alzheimer's brains:: a 31P spectroscopy study
OV Forlenza et al.
PSYCHOPHARMACOLOGY (2005)
Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients
M Zimmermann et al.
NEUROBIOLOGY OF DISEASE (2005)
Oxidative stress related markers in the VITA and the centenarian projects
E Grünblatt et al.
NEUROBIOLOGY OF AGING (2005)
Platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive impairment
WF Gattaz et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease
F Colciaghi et al.
NEUROLOGY (2004)
Cytochrome c oxidase is decreased in Alzheimer's disease platelets
SM Cardoso et al.
NEUROBIOLOGY OF AGING (2004)
Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia Alzheimer type - A 2-year follow-up study
B Borroni et al.
ARCHIVES OF NEUROLOGY (2003)
The genetics of adult-onset neuropsychiatric disease: Complexities and conundra?
JL Kennedy et al.
SCIENCE (2003)
Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to β-amyloid peptide42
A Maddalena et al.
ARCHIVES OF NEUROLOGY (2003)
Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease
M Mancuso et al.
EXPERIMENTAL NEUROLOGY (2003)
Evidence for reduction of pro-atherosclerotic properties in platelets from healthy centenarians
RA Rabini et al.
EXPERIMENTAL GERONTOLOGY (2003)
Amyloid beta-protein interactions with membranes and cholesterol:: causes or casualties of Alzheimer's disease
WG Wood et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2003)
Treatment of mild cognitive impairment: rationale, present and future strategies
V Jelic et al.
ACTA NEUROLOGICA SCANDINAVICA (2003)
Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients
L Emilsson et al.
NEUROSCIENCE LETTERS (2002)
Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease
F Bosetti et al.
NEUROBIOLOGY OF AGING (2002)
The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets
H Rommelspacher et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3β in neuronal apoptosis:: links to tau phosphorylation
W Elyaman et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface
GL Dale et al.
NATURE (2002)
The tau protein of oral epithelium increases in Alzheimer's disease
H Hattori et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2002)
Blood platelet membrane fluidity and the exposition of membrane protein receptors in Alzheimer disease (AD) patients - Preliminary study
W Kozubski et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2002)
Amyloid precursor protein in platelets - A peripheral marker for the diagnosis of sporadic AD
A Padovani et al.
NEUROLOGY (2001)
Cholesterol, a modulator of membrane-associated Aβ-fibrillogenesis and neurotoxicity
CM Yip et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Amyloid precursor protein in platelets of patients with Alzheimer disease -: Effect of acetylcholinesterase inhibitor treatment
B Borroni et al.
ARCHIVES OF NEUROLOGY (2001)
Serotonin 5-HT2A receptor binding in platelets from patients with Alzheimer's disease or vascular dementia
O Spigset et al.
INTERNATIONAL PSYCHOGERIATRICS (2000)
The expanding superfamily of phospholipase A2 enzymes:: classification and characterization
DA Six et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2000)
Paroxetine decreases platelet serotonin storage and platelet function in human beings
N Hergovich et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Ca2+-independent phospholipase A2 inhibitor impairs spatial memory of mice
S Fujita et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2000)
Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus:: Specific changes in Alzheimer's disease
GP Eckert et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2000)
Platelet APP isoform ratios correlate with declining cognition in AD
F Baskin et al.
NEUROLOGY (2000)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
Share Paper
